Our study highlight the significance of HIF-1α in Treg/Th17 balance during aGVHD pathogenesis, and that pharmacological inhibition of HIF-1α represents a promising novel GVHD prophylactic strategy that is worthy of further investigation. Here, HIF1A is linked to graft versus host disease.